Table 1 Demographic characteristics of study participants: Healthy vs. COVID-19 hospital patients.

From: A comprehensive IDA and SWATH-DIA Lipidomics and Metabolomics dataset: SARS-CoV-2 case control study

Parameter

n

Controls

COVID-19 patients

p-value

mean ± SD

mean ± SD

Age (years)

 

68.44 ± 17.45

68.31 ± 17.63

0.974

Sex (Females/Males)

 

17/22

17/22

 

Blood parameters

Erythrocytes G/L)

39/38

4.91 ± 1.27

4.32 ± 0.70

0.014

Lymphocytes G/L)

39/37

1.41 ± 0.58

1.36 ± 2.02

0.012

hs-CRP mg/L)

39/37

2.09 ± 2.50

69.37 ± 61.01

<0.001

HDL mg/dL)

39/21

61.13 ± 14.63

32.90 ± 11.52

<0.001

LDL mg/dL)

39/23

144.50 ± 43.61

81.56 ± 35.14

<0.001

Total Cholesterol mg/dL)

39/23

146.59 ± 46.21

82.78 ± 37.09

<0.001

Blood glucose mg/dL)

39/36

107.13 ± 27.62

130.61 ± 75.71

0.074

ALAT U/L)

39/28

27.90 ± 27.33

40.38 ± 38.73

0.112

ASAT U/L)

39/27

29.79 ± 15.07

40.56 ± 28.44

0.027

UCB µmol/L)

36/37

2.61 ± 3.33

2.79 ± 3.33

0.241

Vitamin D serum level ng/mL)

39/39

22.76 ± 9.57

21.19 ± 12.00

0.527

  1. Data are presented as mean ± standard deviation, p-values are calculated using Mann-Whitney U test for measuring gender differences, significant differences are highlighted with bold numbers. Controls and COVID-19 hospital patients are age and sex-matched. hs-CRP: high sensitivity c-reactive protein; ALAT: Alanine-Aminotransferase; ASAT: Aspartate-Amino Transferase, UCB: unconjugated Bilirubin; HDL: high density lipoprotein; LDL: low density lipoprotein.
Back to article page